US Patent Issued to Takeda Pharmaceutical on April 7 for "Method for enhancing the pharmacokinetics or increasing the plasma concentration of methyl 3-((methylsulfonyl)amino)-2-(((4-phenylcyclohexyl)oxy)methyl)piperidine-1-carboxylate or a salt thereof with an inhibitor of cytochrome P450" (Massachusetts Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,269, issued on April 7, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan).

"Method for enhancing the pharmacokinetics or increasing the plasma concentration of methyl 3-((methylsulfonyl)amino)-2-(((4-phenylcyclohexyl)oxy)methyl)piperidine-1-carboxylate or a salt thereof with an inhibitor of cytochrome P450" was invented by Mark Rogge (Cambridge, Mass.), Helene Faessel (Cambridge, Mass.), Hong Lu (Cambridge, Mass.), Karthik Venkatakrishnan (Cambridge, Mass.), Liming Zhang (Cambridge, Mass.) and John Wagner (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are compositions comprising (a) methyl 3-((methyl su...